Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure

American Heart Journal

Volumn 153, Issue 6, 2007, Pages 1048-1055

  Windram, Jonathan D ^a   Loh, Puan H ^a   Rigby, Alan S ^a   Hanning, Ian ^b   Clark, Andrew L ^a   Cleland, John G F ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN;

AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD EXAMINATION; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DEATH; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HAZARD RATIO; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; MALE; OUTPATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SAMPLE; STATISTICAL SIGNIFICANCE; UNITED STATES; WALKING;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; OUTPATIENTS; PREVALENCE; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34249302024     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.044     Document Type: Article

References (18)

1. Hirshfield G.M., and Pepys M.B. C-reactive protein and cardiovascular disease: new insights from an old molecule. Q J Med 96 (2003) 793-807
2. Rattazzi M., Puato M., Faggin E., et al. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens 21 (2003) 1787-1803
3. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
4. Chirinos J.A., Zamrano J.P., Chakko S., et al. Usefulness of C-reactive protein as an independent predictor of death in patients with ischaemic cardiomyopathy. Am J Cardiol 95 (2005) 88-90
5. Kaneko K., Kanda T., Yamauchi Y., et al. C-reactive protein in dilated cardiomyopathy. Cardiology 91 (1999) 215-219
6. Mueller C., Laule-Kilian K., Christ A., et al. Inflammation and long term mortality n acute congestive heart failure. Am Heart J 151 (2006) 845-850
7. Anand I.S., Latini R., Florea V.G., et al. C reactive protein in heart failure. Prognostic value and the effect of valsartan. Circ 112 (2005) 1428-1434
8. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 16 (1995) 741-751
9. Anker S.D., and Coats A.J. How to RECOVER from RENAISSANCE? The significance of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86 (2002) 123-130
10. Adamopoulos S., Parissis J.T., and Kremastinos D.T. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 3 (2001) 517-526
11. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
12. Bogarty P., Brophy J.M., Boyer L., et al. Fluctuating inflammatory markers in patients with stable ischaemic heart disease. Arch Intern Med 65 (2005) 221-226
13. Joynt K.E., Gattis W.A., Hasselblad V., et al. Effect of angiotensin converting enzyme inhibitors, beta blockers, statins and aspirin on C-reactive protein levels in outpatients with heart failure. Am J Cardiol 93 (2004) 783-785
14. Biasucci L.M., Lombardi M., Piro M., et al. Irbesartan significantly reduces CRP concentrations after 1 month of treatment in unstable angina. Heart 91 (2005) 670-671
15. Horowich T.B., Fonarow G.C., Hamilton M.A., et al. Anaemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
16. Weiss G., and Goodnough L.T. Medical progress: anaemia of chronic disease. N Engl J Med 351 (2004) 799-807
17. Dries D.L., Exener D.V., Domanski M.J., et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
18. Tavazzi L., Tognoni G., Franzosi M.G., et al. Rationale and design of the GISSI heart failure study: a large study to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 6 (2004) 635-641 GISSI-HF